Advertisements
Read Time:11 Second
The United States regulators authorised a second booster dose of Pfizer Inc and BioNTech SE’s Covid-19 vaccine for people 50 and older due to concerns about waning immunity in the age group, the drugmakers said on Tuesday.
Happy
0
0 %
Sad
0
0 %
Excited
0
0 %
Sleepy
0
0 %
Angry
0
0 %
Surprise
0
0 %